Study | Study design | No. of subjects | Model | No. of implants | Harvest material |
Follow-up period |
PR/CT | Histological/HMM | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Total |
Tooth graft group |
Total |
Tooth graft group |
Study group | Comparison group | ||||||
Jun et al. [15] | Prospective study | 43 | 22 | Human | 57 | 29 | AutoBT | Bio-Oss® | 4 months | + | + |
Jeong et al. [16] | Retrospective comparative | 26 | 8 | Human | N/A | AutoBT | DFDBA, DBBM | 6 months | + | - | |
Kim et al. [17] | Retrospective comparative | 37 | 17 | Human | 34 | 18 | AutoBT | Synthetic bone grafts | 12 months | + | - |
Kim et al. [18] | Prospective | 30 | 15 | Human | 59 | 28 | AutoFDT block + PRP | Allograft and xenograft powder + PRP | 24 months | + | + |
Lee et al. [19] | Animal clinical | 5 | Minipigs | N/A | AutoBT | Synthetic hydroxyapetite | 12 weeks | - | + | ||
Sohn et al. [20] | Animal clinical | 18 | Rabbits | N/A | DTD | Blood clots alone, β-TCP | 2, 4, 8 weeks | - | + | ||
Xu et al. [21] | Animal experimental | 8 | Rabbits | N/A | Demineralized particulate human tooth | Bio-Oss® | 2,8 weeks | - | + |
HMM = histomorphometric; PR = panoramic radiography; CT = computed tomography; PRP = platelet rich plasma; autoBT = autogenous tooth bone graft; autoFDT = autogenous fresh demineralized tooth; DTD = demineralized tooth dentin; DFDBA = demineralized freeze-dried bone allograft; DBBM = deproteinized bovine bone mineral; β-TCP = β-tricalcium phosphate; - = not indicated. |